Stoeckel Luke E, Arvanitakis Zoe, Gandy Sam, Small Dana, Kahn C Ronald, Pascual-Leone Alvaro, Pawlyk Aaron, Sherwin Robert, Smith Philip
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
F1000Res. 2016 Mar 15;5:353. doi: 10.12688/f1000research.8300.2. eCollection 2016.
Scientific evidence has established several links between metabolic and neurocognitive dysfunction, and epidemiologic evidence has revealed an increased risk of Alzheimer's disease and vascular dementia in patients with diabetes. In July 2015, the National Institute of Diabetes, Digestive, and Kidney Diseases gathered experts from multiple clinical and scientific disciplines, in a workshop entitled "The Intersection of Metabolic and Neurocognitive Dysfunction", to clarify the state-of-the-science on the mechanisms linking metabolic dysfunction, and insulin resistance and diabetes in particular, to neurocognitive impairment and dementia. This perspective is intended to serve as a summary of the opinions expressed at this meeting, which focused on identifying gaps and opportunities to advance research in this emerging area with important public health relevance.
科学证据已证实代谢功能障碍与神经认知功能障碍之间存在多种联系,流行病学证据也显示糖尿病患者患阿尔茨海默病和血管性痴呆的风险增加。2015年7月,美国国立糖尿病、消化和肾脏疾病研究所召集了来自多个临床和科学领域的专家,举办了一场题为“代谢功能障碍与神经认知功能障碍的交叉点”的研讨会,以阐明将代谢功能障碍,尤其是胰岛素抵抗和糖尿病与神经认知障碍及痴呆联系起来的机制的科学现状。本观点旨在总结本次会议上表达的意见,会议重点是找出该新兴领域研究中的差距和机会,以推动具有重要公共卫生意义的研究。